Drug Shortage Report for AVAPRO

Last updated on 2019-11-05 History
Report ID 89212
Drug Identification Number 02237923
Brand name AVAPRO
Common or Proper name Avapro
Market Status MARKETED
Active Ingredient(s) IRBESARTAN
Strength(s) 75MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 90
ATC code C09CA
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-06-17
Estimated end date 2019-11-15
Actual end date 2019-11-04
Shortage status Resolved
Updated date 2019-11-05
Company comments Increase in demand, supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2019-11-05 French Compare
v9 2019-11-05 English Compare
v8 2019-10-02 French Compare
v7 2019-10-02 English Compare
v6 2019-10-02 French Compare
v5 2019-10-02 English Compare
v4 2019-10-02 French Compare
v3 2019-10-02 English Compare
v2 2019-07-12 French Compare
v1 2019-07-12 English Compare

Showing 1 to 10 of 10